4.2000
-0.0500
(-1.18%)
At close: April 17 at 3:35:26 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.17 | -0.15 | -0.59 | -0.17 |
| Low Estimate | -0.17 | -0.15 | -0.59 | -0.17 |
| High Estimate | -0.17 | -0.15 | -0.59 | -0.17 |
| Year Ago EPS | -0.19 | -0.29 | -0.62 | -0.59 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 4 |
| Avg. Estimate | 12.52M | 14.66M | 57.28M | 62.68M |
| Low Estimate | 11.3M | 14M | 56.5M | 60.3M |
| High Estimate | 13.4M | 15.3M | 59.2M | 66.9M |
| Year Ago Sales | 12.47M | 14.52M | 56.62M | 57.28M |
| Sales Growth (year/est) | 0.38% | 0.97% | 1.17% | 9.42% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.18 | -0.14 | -0.09 |
| EPS Actual | -0.19 | -0.29 | -0.15 | -0.1 |
| Difference | -0.02 | -0.11 | -0.01 | -0.01 |
| Surprise % | -11.76% | -59.17% | -7.14% | -11.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.15 | -0.59 | -0.17 |
| 7 Days Ago | -0.17 | -0.15 | -0.59 | -0.23 |
| 30 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
| 60 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
| 90 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLS.TO | 10.53% | 47.64% | 4.84% | 71.19% |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Maintains | Raymond James: Market Perform to Market Perform | 3/18/2024 |
| Downgrade | Raymond James: Outperform to Market Perform | 8/6/2021 |
Related Tickers
DHT-UN.TO DRI Healthcare Trust
11.24
-0.71%
LSL.V LSL Pharma Group Inc.
0.3450
-1.43%
MDP.TO Medexus Pharmaceuticals Inc.
2.5500
+8.51%
CTX.TO Crescita Therapeutics Inc.
0.5900
0.00%
GUD.TO Knight Therapeutics Inc.
5.69
-0.52%
MOB.ST Moberg Pharma AB (publ)
7.70
-1.41%
ANIK Anika Therapeutics, Inc.
14.02
+4.08%
CPH.TO Cipher Pharmaceuticals Inc.
11.91
+0.85%
BCRX BioCryst Pharmaceuticals, Inc.
7.40
+2.49%
AKBA Akebia Therapeutics, Inc.
2.0600
+8.42%